VLS

About VLS

Vita Life Sciences Limited (VLS) is a multinational healthcare Company involved in formulating, packaging, sales and distribution of vitamins and supplements. Vita Life Sciences is represented by two major brands of high quality supplements throughout the Asia-Pacific region, Vita Health and Herbs of Gold.

Buy Australian shares starting with VLS. Invest today with a CHESS-sponsored investing platform!

Announcements

What does Vita Life Sciences (VLS) do?

It's a feel-good business.

Founded in 1947 and headquartered in Kirrawee, Australia, Vita Life Sciences Limited is a healthcare company that works with qualified naturopaths, nutritionists, biotechnologists and pharmacists to formulate over-the-counter (OTC) medicines, complementary and alternative medicines, dietary supplements and health foods. These are packaged, distributed and sold throughout Australia, Southeast Asia and China.

Under three consumer brands – Herbs of Gold, VitaHealth, and VitaScience – there are approximately 800 registered products designed to help with immunity, healthy development of hair, skin and nails, liver health, digestion, weight management, inflammation, cardio health, breastfeeding and much more.

How does Vita Life Sciences make money?

Vita Life Sciences (VLS) earns revenue by marketing and selling its products through pharmacies and health food retailers. It does not calculate its earnings via its three brands, but rather by geography.

The geographies are Australia, Singapore, Malaysia and Others. The Others category groups revenue from Thailand, Vietnam, Indonesia, and China.

The Australia segment is currently Vita Life Science’s biggest earner. In FY2021, it earned $30.3m. The Malaysia segment came second, earning $19.2m. Singapore earned $5.6m and Others earned a bit over $2m.

How do I buy VLS stock?

Stake offers a quick and easy way to purchase VLS shares – along with 2,000+ other Australian stocks and ASX ETFs – for a brokerage fee of only A$3.

Stake is a CHESS sponsored broker, meaning that when you buy ASX shares, you get a HIN (Holder Identification Number) and stocks are held in your name.

With Stake, you can be in the market in under 5 minutes, whether it's the ASX or Wall St. If you’re interested in building your portfolio by adding VLS, sign up today.

Is Vita Life Sciences a profitable company?

Yes, Vita Life Sciences is a profitable and healthy company.

Just over the past three financial years, the company’s net income has grown from $3.14m in FY2019 to $6.09m in FY2020 to $8.29m in FY2021. The company’s balance sheet is strong with zero debt and net cash of $16m.

Does Vita Life Sciences (VLS) pay a dividend?

Yes, for FY2021, the company paid a dividend of A$0.0575 per share, an increase of over 35% from FY2020’s dividend of A$0.0425.

Vita Life Sciences has historically paid dividends in March and September each year.

Is VLS stock a buy?

Investor sentiment around Vita Life Sciences is generally positive. 

The company has proven to be a consistent generator of profits and pays a reasonable dividend. The company also has grand plans for the next three financial years to continue driving consumer and retailer engagement. They aim to do so by building their brand, offering education programs to support their products and recruiting more personnel.

Investors who are bearish about Vita Life Sciences’ prospects cite pandemic interruptions and supply chain issues as reasons not to buy.

Who owns VLS stock?

As of 28 February 2022, Vita Life Sciences top shareholders include Chemical Trustee Limited (15.50%), billionaire investor Vicky Teoh (15.30%), Barings Acceptance Limited (13.4%), Anglo Australian Christian and Charitable Fund (11.4%), and former Managing Director Eddie Tie Lim Sung (7.9%).